All
Aesthetic evolution: Filler technologies improve; choices widen
October 1st 2008When Reloxin (Ipsen) eventually hits the U.S. market to challenge Botox (Allergan) as the new 800-pound gorilla of the facial aesthetics market, then it will be accurate to report the arrival of a new product with potentially huge market impact, dermatology sources say.
Study shows spring water helps treat childhood eczema
September 8th 2008World report - Research shows patients with atopic eczema saw significant improvements after applying creams with the harmless bacteria Vitreoscilla filiformis, commonly found in thermal springs and spas, the Telegraph.co.uk reports.
The language of skin: Lexicon project codifies dermatology’s terminology for digital age
September 8th 2008National report - The Dermatology Lexicon Project (DLP) promises to provide the specialty with the foundation it needs to enter an age of computerized medical information. The multi-year project, taken over by the American Academy of Dermatology a few years ago, is the first-of-its-kind comprehensive dermatology terminology lexicon, created to support dermatology research, medical informatics and clinical care.
Bonding your portfolio: Diversifying investments, large or small, will minimize risks
September 1st 2008One of the most challenging financial decisions you need to make these days is where to put your money. Whether your investment portfolio is large or small, you must choose from among mutual funds, individual stocks or bonds, or simply stashing away your cash in bank accounts, money market accounts or other cash equivalents.
Choosing therapy: Weigh options carefully for immunocompromised patients
September 1st 2008As immunocompromised patients, and those with genodermatoses, have a significantly increased risk of developing skin cancer, physicians should carefully weigh their choices of therapy from the start, to avoid precluding future therapies when these patients may need them most.
Public enemy No. 1: Melanoma incognito cunningly mimics benign lesion
September 1st 2008A thorough dermoscopic evaluation of each and every skin tumor in patients can prove invaluable in accurately diagnosing dangerous skin tumors such as melanoma incognito. One expert applies seven "golden rules" to help better manage patients with skin tumors, and to home in on which lesions should be biopsied and which should not.
On the safe side: New classification 'Spitzoid tumor' signals cautious treatment
September 1st 2008Histopathologists have coined the term "Spitzoid tumor" for ambiguous diagnoses of spitzoid lesions. According to one expert, such patients are now more carefully treated and followed, as such a shaky diagnosis forces dermatologists to take serious precautions in treatment.
Weighing the risks: Biologics used to treat rheumatoid arthritis pose minimal cancer threat
September 1st 2008A large observational study shows a risk of melanoma and nonmelanotic skin cancer associated with biologic use for rheumatoid arthritis; however, this risk is slight, the study's lead author says.